EVALUATION OF PACLITAXEL (TAXOL, NSC #673089), CARBOPLATIN (PARAPLATIN, NSC #241240), AND BSI-201 (NSC #746045, IND #71,677) IN THE TREATMENT OF ADVANCED, PERSISTENT, OR RECURRENT UTERINE CARCINOSARCOMA: